Shopping Cart
Remove All
Your shopping cart is currently empty
Enflicoxib is an efficacious and safe agent for the treatment of pain and inflammation across all stages of canine osteoarthritis. Enflicoxib demonstrates a faster onset of action compared to mavacoxib, offering an improved pharmacological profile for veterinary applications.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $32 | - | In Stock | |
| 5 mg | Preferential | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $199 | - | In Stock |
| Description | Enflicoxib is an efficacious and safe agent for the treatment of pain and inflammation across all stages of canine osteoarthritis. Enflicoxib demonstrates a faster onset of action compared to mavacoxib, offering an improved pharmacological profile for veterinary applications. |
| In vivo | Pharmacokinetic studies of Enflicoxib were conducted following single oral and intravenous administration in rats and dogs. In both animal species, E-6087 was characterized by a long elimination half-life (20-35 hours), low plasma clearance (0.10-0.22 l h(-1) kg(-1)), and a relatively large volume of distribution (2-6 l kg(-1)). Oral bioavailability was lower in dogs compared to rats, while absorption occurred more rapidly in rats. [2] |
| Synonyms | E6087, E 6087 |
| Molecular Weight | 405.34 |
| Formula | C16H12F5N3O2S |
| Cas No. | 251442-94-1 |
| Smiles | O=S(=O)(N)C1=CC=C(C=C1)N2N=C(CC2C3=CC=C(F)C=C3F)C(F)(F)F |
| Relative Density. | 1.57 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (197.37 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.